The services provided are really good. The website is well-designed and easy to navigate. I am satisfied with Cue Biopharma.
Haven't used Cue Biopharma yet?
Ask AI
Ask AI about Cue Biopharma
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
AI-generated from reviews on this page. Verify anything important with the company directly.
9 Reviews
👍 Cue Biopharma is an excellent company. Their website is informative and user-friendly. I had a great experience using their services.
😊 Cue Biopharma is a fantastic company to work with. They have an amazing website and provide excellent services.
👌 Cue Biopharma provides great services. I had a wonderful experience using their website.
The company is doing a decent job. They have a good website and provide reliable services. I appreciate their efforts.
I had a good experience with Cue Biopharma. Their website is informative and user-friendly. I recommend them.
The services provided by Cue Biopharma are great. They have a well-organized website and offer excellent support to their customers.
Cue Biopharma is an average company. They provide good services and have a user-friendly website. Overall, I had a satisfactory experience.
I love Cue Biopharma! Their website is great and they provide excellent services. I am very happy with them. ❤️
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
or with email
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About Cue Biopharma
Cue Biopharma (Cue) is an immunotherapy company developing biologics engineered to selectively modulate disease-relevant T cells for the treatment of cancer and autoimmune disease. Cue biologics generate tailored immune responses in disease-relevant T cell populations by emulating the signals, or cues, delivered by the body’s antigen-presenting cells (APCs), and can potentially address any T cell-mediated disease. Through this platform approach, Cue has developed a portfolio of promising drug candidates with two lead programs currently approaching the clinic.
Headquartered in Kendall Square, Cambridge, Massachusetts, Cue is led by a strong, experienced management team and scientific advisory board (SAB) with deep expertise in the design and clinical development of protein biologics, immunology, and immuno-oncology.
- Website
- cuebiopharma.com
